Veer Bhavnagri Allogene Therapeutics, Inc. (ALLO) insider trading activity

Veer Bhavnagri is General Counsel of Allogene Therapeutics, Inc.. Currently has a direct ownership of 556,049 shares of ALLO, which is worth approximately $1.04 Million. The most recent transaction as insider was on Mar 14, 2023, when has been sold 23,628 shares (Common Stock) at a price of $5.67 per share, resulting in proceeds of $133,970. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 556K

0% 3M change

0% 12M change

Total Value Held $1.04 Million

Veer Bhavnagri Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 14 2023	SELL Payment of exercise price or tax liability	$133,970 $5.67 p/Share	23,628 Reduced 4.08%	556,049 Common Stock
Feb 13 2023	SELL Open market or private sale	$20,550 $6.85 p/Share	3,000 Reduced 0.52%	577,677 Common Stock
Jan 17 2023	SELL Open market or private sale	$21,120 $7.04 p/Share	3,000 Reduced 0.51%	580,677 Common Stock
Dec 15 2022	SELL Open market or private sale	$42,183 $7.53 p/Share	5,602 Reduced 0.95%	583,677 Common Stock
Mar 23 2022	BUY Grant, award, or other acquisition	-	175,438 Added 22.94%	589,279 Common Stock
Mar 15 2022	SELL Open market or private sale	$67,960 $7.68 p/Share	8,849 Reduced 2.09%	413,841 Common Stock
Sep 15 2021	SELL Open market or private sale	$123,850 $24.77 p/Share	5,000 Reduced 1.17%	421,669 Common Stock
Sep 15 2021	BUY Exercise of conversion of derivative security	$11,350 $2.27 p/Share	5,000 Added 1.16%	426,669 Common Stock
Aug 16 2021	SELL Open market or private sale	$105,000 $21.0 p/Share	5,000 Reduced 1.17%	421,353 Common Stock
Aug 16 2021	BUY Exercise of conversion of derivative security	$11,350 $2.27 p/Share	5,000 Added 1.16%	426,353 Common Stock
Jul 15 2021	SELL Open market or private sale	$107,750 $21.55 p/Share	5,000 Reduced 1.17%	421,353 Common Stock
Jul 15 2021	BUY Exercise of conversion of derivative security	$11,350 $2.27 p/Share	5,000 Added 1.16%	426,353 Common Stock
Jun 15 2021	SELL Open market or private sale	$126,600 $25.32 p/Share	5,000 Reduced 1.17%	421,353 Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	$11,350 $2.27 p/Share	5,000 Added 1.16%	426,353 Common Stock
May 18 2021	SELL Open market or private sale	$150,000 $30.0 p/Share	5,000 Reduced 1.17%	421,353 Common Stock
May 18 2021	BUY Exercise of conversion of derivative security	$11,350 $2.27 p/Share	5,000 Added 1.16%	426,353 Common Stock
May 17 2021	SELL Open market or private sale	$141,500 $28.3 p/Share	5,000 Reduced 1.17%	421,353 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	$11,350 $2.27 p/Share	5,000 Added 1.16%	426,353 Common Stock
Apr 15 2021	SELL Open market or private sale	$323,200 $32.32 p/Share	10,000 Reduced 2.32%	421,353 Common Stock
Apr 15 2021	BUY Exercise of conversion of derivative security	$22,700 $2.27 p/Share	10,000 Added 2.27%	431,353 Common Stock
Mar 26 2021	BUY Grant, award, or other acquisition	-	22,202 Added 5.01%	421,353 Common Stock
Mar 15 2021	SELL Open market or private sale	$632,173 $38.03 p/Share	16,623 Reduced 4.0%	399,151 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$22,700 $2.27 p/Share	10,000 Added 2.35%	415,774 Common Stock
Dec 17 2020	BUY Exercise of conversion of derivative security	$116,905 $2.27 p/Share	51,500 Added 11.27%	405,402 Common Stock
Oct 06 2020	SELL Open market or private sale	$400,000 $40.0 p/Share	10,000 Reduced 2.75%	353,902 Common Stock

Veer Bhavnagri

General Counsel

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Value

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Allogene Therapeutics, Inc.

Track Activities on ALLO

Account